CompanyGraphWhat stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 3
- ScaleMarket cap is $5.87B, above the global median of $1.18B
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
8.14TKRW5.87B · vs all stocks (USD)
Revenue (TTM)
1.51TKRW1.09B · vs all stocks (USD)
Profit Margin
33.90%vs Biotechnology peers
52-Week Change
-25.43%vs all stocks
Market Capitalization
8.14TKRW5.87B · vs all stocks (USD)
Enterprise Value
8.75TKRW6.32B · vs all stocks (USD)
Forward P/E
22.38xvs Biotechnology peers
Price to Sales (TTM)
5.39xvs Biotechnology peers
Enterprise to Revenue
5.79xvs Biotechnology peers
Profit Margin
33.90%vs Biotechnology peers
Operating Margin
19.95%vs Biotechnology peers
Revenue (TTM)
1.51TKRW1.09B · vs all stocks (USD)
Revenue per Share (TTM)
60.76KKRWUpdated Sep 19, 2026Gross Profit (TTM)
546.02BKRW394.12M · vs all stocks (USD)
EBITDA (TTM)
26.82BKRW19.36M · vs all stocks (USD)
Net Income (TTM)
511.88BKRW369.47M · vs all stocks (USD)
Operating Cash Flow (TTM)
-622.47BKRW-449.30M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
0.00KRWvs all stocks (USD)
Shares Outstanding
24.88MSharesUpdated Sep 19, 2026Float Shares
6.35MSharesUpdated Sep 19, 2026% Held by Insiders
74.29%vs all stocks
% Held by Institutions
11.80%vs all stocks
Total Cash (MRQ)
113.52BKRW81.94M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.57KKRWUpdated Sep 19, 2026Total Debt (MRQ)
743.20BKRW536.44M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1237xvs Biotechnology peers
Current Ratio (MRQ)
1.36xvs Biotechnology peers
52-Week Low
325.50KKRWUpdated Sep 19, 202652-Week High
773.00KKRWUpdated Sep 19, 202652-Week Change
-25.43%vs all stocks
50-Day MA
374.91KKRWUpdated Sep 19, 2026200-Day MA
510.29KKRWUpdated Sep 19, 2026Avg 10-Day Volume
32.63KSharesUpdated Sep 19, 2026Avg 30-Day Volume
71.81KSharesUpdated Sep 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 369,474,229.725Operating Cash Flow (USD, TTM): -449,298,778.463
Supply Chain
Upstream position: supplies 6 industries, depends on 3Notable
Outgoing: 6.00Incoming: 3.00
Scale
Market cap is $5.87B, above the global median of $1.18BNotable
Market cap (USD): 5,873,111,219.201Global Median: 1,180,223,658.953
Revenue is $1.09B, above the global median of $548.88MNotable
Revenue (USD): 1,090,018,876.273Global Median: 548,883,780.48
Companies that share the same coordination system — how they create, deliver, or capture value.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Mirum Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Scholar Rock Holding Corporation
Tier 1ProductionApproval-Gated PipelineRuleRisk
CG Oncology, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Kiniksa Pharmaceuticals International, plc
Tier 1ProductionApproval-Gated PipelineRule
Shenzhen New Industries Biomedical Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Liquidia Corporation
Tier 1ProductionApproval-Gated PipelineRule
Cogent Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Travere Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sectra AB
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking